Kura Oncology (KURA) Stock Highlights

18 | -0.5%

2024-10-21 02:30:02

Kura Oncology Inc is a clinical-stage biopharmaceutical company, that engages in discovering and developing therapeutics for the treatment of solid tumors and blood cancers. It focuses on the development of small-molecule product candidates that target cell signalling pathways to drive the progression of various cancers. The company has a lead product candidate, Tipifarnib, which is a farnesyl transferase inhibitor, in both solid tumors and blood cancers. It is advancing KO-947, a small molecule inhibitor of extracellular-signal-regulated kinase (ERK), as a treatment for patients with pancreatic cancer, colorectal cancer, non-small cell lung cancer (NSCLC) and melanoma. Geographically operation of the group is carried through the United States.

Statistics

Range Today

17.85 18.36

Volume Today 251.3K

Range 1 Year

7.41 24.17

Volume 1 Year 234.59M

Range 3 Year

7.41 24.17

Volume 3 Year 630.94M

Range 10 Year

2.5 43

Volume 10 Year 1.17B

Highlights

Market Capitalization 1.38B (small)

Floating Shares 49.09M

Current Price 18

Price To Earnings -8.11

Price To Book 2.95

Earnings Per Share -2.23

Payout Ratio 0%

Performance

Latest -0.5%

1 Month -10.8%

3 Months -17.05%

6 Months +0.78%

1 Year +106.19%

3 Years +0.28%

5 Years +21.05%

10 Years +20%

Benchmarks

Market Capitalization

0 / 368

Gross Profits

0 / 278

Total Revenue

0 / 300

Total Rank

0 / 368

Free Cashflow

0 / 352

Performance 5 years

0 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.